481 related articles for article (PubMed ID: 9932729)
1. Triflavin potentiates the antiplatelet activity of platelet activating factor receptor antagonist on activated neutrophil-induced platelet aggregation.
Lee LW; Peng HC; Ko WC; Hung WC; Su CH; Lin CH; Huang TF; Yen MH; Sheu JR
Eur J Pharmacol; 1999 Jan; 364(2-3):239-46. PubMed ID: 9932729
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of the platelet aggregation induced by activated neutrophils and inhibitory effect of specific PAF receptor antagonists.
Nguyên P; Petitfrère E; Potron G
Thromb Res; 1995 Apr; 78(1):33-42. PubMed ID: 7778064
[TBL] [Abstract][Full Text] [Related]
3. Sensitization of human neutrophil defense activities through activation of platelet-activating factor receptors by ginkgolide B, a bioactive component of the Ginkgo biloba extract EGB 761.
Lenoir M; Pedruzzi E; Rais S; Drieu K; Perianin A
Biochem Pharmacol; 2002 Apr; 63(7):1241-9. PubMed ID: 11960600
[TBL] [Abstract][Full Text] [Related]
4. Cell adhesion by membrane-bound paf-acether.
Ninio E; Leyravaud S; Bidault J; Jurgens P; Benveniste J
Int Immunol; 1991 Nov; 3(11):1157-63. PubMed ID: 1760410
[TBL] [Abstract][Full Text] [Related]
5. Triflavin, an Arg-Gly-Asp containing snake venom peptide, inhibits aggregation of human platelets induced by human hepatoma cell line.
Sheu JR; Lin CH; Chung JL; Teng CM; Huang TF
Thromb Res; 1992 Jun; 66(6):679-91. PubMed ID: 1519227
[TBL] [Abstract][Full Text] [Related]
6. Characterization of receptors for platelet-activating factor on platelets, polymorphonuclear leukocytes and macrophages.
Stewart AG; Dusting GJ
Br J Pharmacol; 1988 Aug; 94(4):1225-33. PubMed ID: 2850058
[TBL] [Abstract][Full Text] [Related]
7. Triflavin, an antiplatelet Arg-Gly-Asp-containing peptide, is a specific antagonist of platelet membrane glycoprotein IIb-IIIa complex.
Huang TF; Sheu JR; Teng CM; Chen SW; Liu CS
J Biochem; 1991 Feb; 109(2):328-34. PubMed ID: 1864844
[TBL] [Abstract][Full Text] [Related]
8. Short-term and long-term role of platelet activating factor as a mediator of in vivo platelet aggregation.
Golino P; Ambrosio G; Ragni M; Pascucci I; Triggiani M; Oriente A; McNatt J; Buja LM; Condorelli M; Chiariello M
Circulation; 1993 Sep; 88(3):1205-14. PubMed ID: 8353882
[TBL] [Abstract][Full Text] [Related]
9. 1,4-Dihydropyridines, a new class of platelet-activating factor receptor antagonists: in vitro pharmacologic studies.
Ortega MP; García MC; Gijón MA; de Casa-Juana MF; Priego JG; Sanchez Crespo M; Sunkel C
J Pharmacol Exp Ther; 1990 Oct; 255(1):28-33. PubMed ID: 2170624
[TBL] [Abstract][Full Text] [Related]
10. Prehispanolone, a novel platelet activating factor receptor antagonist from Leonurus heterophyllus.
Lee CM; Jiang LM; Shang HS; Hon PM; He Y; Wong HN
Br J Pharmacol; 1991 Jul; 103(3):1719-24. PubMed ID: 1657264
[TBL] [Abstract][Full Text] [Related]
11. Inhibition by BN 52021 (ginkgolide B) of the binding of [3H]-platelet-activating factor to human neutrophil granulocytes.
Földes-Filep E; Braquet P; Filep J
Biochem Biophys Res Commun; 1987 Nov; 148(3):1412-7. PubMed ID: 2825685
[TBL] [Abstract][Full Text] [Related]
12. Changes in cytosolic free calcium induced by platelet-activating factor in rabbit platelets: specific inhibition by BN 52021 and structurally related compounds.
Baroggi N; Etienne A; Braquet P
Agents Actions Suppl; 1986; 20():87-97. PubMed ID: 3028108
[TBL] [Abstract][Full Text] [Related]
13. Platelet-activating factor (PAF) receptor antagonists inhibit arachidonic acid induced platelet aggregation in rabbit whole blood.
Ammit AJ; O'Neill C
Lipids; 1991 Dec; 26(12):1189-92. PubMed ID: 1668116
[TBL] [Abstract][Full Text] [Related]
14. Comparison of three paf-acether receptor antagonist ginkgolides.
Korth R; Nunez D; Bidault J; Benveniste J
Eur J Pharmacol; 1988 Jul; 152(1-2):101-10. PubMed ID: 2850196
[TBL] [Abstract][Full Text] [Related]
15. CIS-19, a novel platelet activating factor receptor antagonist: in vitro and in vivo studies.
Ko FN; Yu SM; Chen IS; Ishii H; Chang YL; Huang TF; Teng CM
Biochim Biophys Acta; 1993 Jan; 1175(2):225-31. PubMed ID: 8380343
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of the PAF receptor antagonist UK-74,505 on neutrophil and eosinophil accumulation in guinea-pig skin.
Sanz MJ; Weg VB; Walsh DT; Williams TJ; Nourshargh S
Br J Pharmacol; 1994 Oct; 113(2):513-21. PubMed ID: 7834203
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of platelet-activating factor (PAF)-induced chemotaxis and PAF binding to human eosinophils and neutrophils by the specific ginkgolide-derived PAF antagonist, BN 52021.
Kurihara K; Wardlaw AJ; Moqbel R; Kay AB
J Allergy Clin Immunol; 1989 Jan; 83(1):83-90. PubMed ID: 2536413
[TBL] [Abstract][Full Text] [Related]
18. Effects of WEB 2086, an antagonist to the receptor for platelet-activating factor (PAF), on PAF-induced responses in the horse.
Foster AP; Lees P; Andrews MJ; Cunningham FM
Equine Vet J; 1992 May; 24(3):203-7. PubMed ID: 1318830
[TBL] [Abstract][Full Text] [Related]
19. Platelet-activating factor and antagonists modulate DNA synthesis in human bone marrow stromal cell cultures.
Rougier F; Dupuis F; Cornu E; Dulery C; Praloran V; Denizot Y
J Lipid Mediat Cell Signal; 1997 Jul; 16(3):147-53. PubMed ID: 9246604
[TBL] [Abstract][Full Text] [Related]
20. [Effect of BN52021 on platelet activating factor induced aggregation of psoriatic polymorphonuclear neutrophils].
Liu BJ; Zhang HT; Zheng MR
Zhonghua Yi Xue Za Zhi; 1994 Jun; 74(6):370-2, 392. PubMed ID: 7994650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]